200 related articles for article (PubMed ID: 29051270)
1. Hypoxia-induced PD-L1/PD-1 crosstalk impairs T-cell function in sleep apnoea.
Cubillos-Zapata C; Avendaño-Ortiz J; Hernandez-Jimenez E; Toledano V; Casas-Martin J; Varela-Serrano A; Torres M; Almendros I; Casitas R; Fernández-Navarro I; Garcia-Sanchez A; Aguirre LA; Farre R; López-Collazo E; García-Rio F
Eur Respir J; 2017 Oct; 50(4):. PubMed ID: 29051270
[TBL] [Abstract][Full Text] [Related]
2. Age-dependent hypoxia-induced PD-L1 upregulation in patients with obstructive sleep apnoea.
Cubillos-Zapata C; Balbás-García C; Avendaño-Ortiz J; Toledano V; Torres M; Almendros I; Casitas R; Zamarrón E; García-Sánchez A; Feliu J; Aguirre LA; Farre R; López-Collazo E; García-Rio F
Respirology; 2019 Jul; 24(7):684-692. PubMed ID: 30656807
[TBL] [Abstract][Full Text] [Related]
3. Redistribution of Monocyte Subsets in Obstructive Sleep Apnea Syndrome Patients Leads to an Imbalanced PD-1/PD-L1 Cross-Talk with CD4/CD8 T Cells.
Polasky C; Steffen A; Loyal K; Lange C; Bruchhage KL; Pries R
J Immunol; 2021 Jan; 206(1):51-58. PubMed ID: 33268482
[TBL] [Abstract][Full Text] [Related]
4. Extracellular vesicles derived from lung cancer cells exposed to intermittent hypoxia upregulate programmed death ligand 1 expression in macrophages.
Liu Y; Lu M; Chen J; Li S; Deng Y; Yang S; Ou Q; Li J; Gao P; Luo Z; Yuan P; Tan J; Gao X
Sleep Breath; 2022 Jun; 26(2):893-906. PubMed ID: 34254261
[TBL] [Abstract][Full Text] [Related]
5. Differential effect of intermittent hypoxia and sleep fragmentation on PD-1/PD-L1 upregulation.
Cubillos-Zapata C; Almendros I; Díaz-García E; Toledano V; Casitas R; Galera R; López-Collazo E; Farre R; Gozal D; García-Rio F
Sleep; 2020 May; 43(5):. PubMed ID: 31782790
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of Monocyte Subsets and PD-L1 Expression but Not T Cell PD-1 Expression in Obstructive Sleep Apnea Patients upon PAP Therapy.
Polasky C; Steffen A; Loyal K; Lange C; Bruchhage KL; Pries R
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768806
[TBL] [Abstract][Full Text] [Related]
7. Glial cells suppress postencephalitic CD8+ T lymphocytes through PD-L1.
Schachtele SJ; Hu S; Sheng WS; Mutnal MB; Lokensgard JR
Glia; 2014 Oct; 62(10):1582-94. PubMed ID: 24890099
[TBL] [Abstract][Full Text] [Related]
8. PD-L1/PD-1 crosstalk in colorectal cancer: are we targeting the right cells?
Cantero-Cid R; Casas-Martin J; Hernández-Jiménez E; Cubillos-Zapata C; Varela-Serrano A; Avendaño-Ortiz J; Casarrubios M; Montalbán-Hernández K; Villacañas-Gil I; Guerra-Pastrián L; Peinado B; Marcano C; Aguirre LA; López-Collazo E
BMC Cancer; 2018 Oct; 18(1):945. PubMed ID: 30285662
[TBL] [Abstract][Full Text] [Related]
9. Expression of programmed death-1 (PD-1) and its ligand PD-L1 is upregulated in endometriosis and promoted by 17beta-estradiol.
Wu L; Lv C; Su Y; Li C; Zhang H; Zhao X; Li M
Gynecol Endocrinol; 2019 Mar; 35(3):251-256. PubMed ID: 30325236
[TBL] [Abstract][Full Text] [Related]
10. PD-1-expressing B cells suppress CD4
Wang X; Wang G; Wang Z; Liu B; Han N; Li J; Lu C; Liu X; Zhang Q; Yang Q; Wang G
Mol Immunol; 2019 May; 109():20-26. PubMed ID: 30851633
[TBL] [Abstract][Full Text] [Related]
11. Blocking Triggering Receptor Expressed on Myeloid Cells-1-Positive Tumor-Associated Macrophages Induced by Hypoxia Reverses Immunosuppression and Anti-Programmed Cell Death Ligand 1 Resistance in Liver Cancer.
Wu Q; Zhou W; Yin S; Zhou Y; Chen T; Qian J; Su R; Hong L; Lu H; Zhang F; Xie H; Zhou L; Zheng S
Hepatology; 2019 Jul; 70(1):198-214. PubMed ID: 30810243
[TBL] [Abstract][Full Text] [Related]
12. Nafamostat mesilate, a serine protease inhibitor, suppresses interferon-gamma-induced up-regulation of programmed cell death ligand 1 in human cancer cells.
Homma S; Hayashi K; Yoshida K; Sagawa Y; Kamata Y; Ito M
Int Immunopharmacol; 2018 Jan; 54():39-45. PubMed ID: 29100036
[TBL] [Abstract][Full Text] [Related]
13. Infiltration of CD8 T Cells and Expression of PD-1 and PD-L1 in Synovial Sarcoma.
Nowicki TS; Akiyama R; Huang RR; Shintaku IP; Wang X; Tumeh PC; Singh A; Chmielowski B; Denny C; Federman N; Ribas A
Cancer Immunol Res; 2017 Feb; 5(2):118-126. PubMed ID: 28039162
[TBL] [Abstract][Full Text] [Related]
14. Highly Activated PD-1/PD-L1 Pathway in Gastric Cancer with PD-L1 Expression.
Saito H; Kono Y; Murakami Y; Shishido Y; Kuroda H; Matsunaga T; Fukumoto Y; Osaki T; Ashida K; Fujiwara Y
Anticancer Res; 2018 Jan; 38(1):107-112. PubMed ID: 29277762
[TBL] [Abstract][Full Text] [Related]
15. Menopausal status influences the expression of programmed death (PD)-1 and its ligand PD-L1 on immune cells from the human female reproductive tract.
Shen Z; Rodriguez-Garcia M; Patel MV; Barr FD; Wira CR
Am J Reprod Immunol; 2016 Aug; 76(2):118-25. PubMed ID: 27321759
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo effect of PD-1/PD-L1 blockade on microglia/macrophage activation and T cell subset balance in cryptococcal meningitis.
Che YM; Zhang Y; Li M; Li XP; Zhang LL
J Cell Biochem; 2018 Apr; 119(4):3044-3057. PubMed ID: 29058791
[TBL] [Abstract][Full Text] [Related]
17. Programmed death ligand-1 expression on donor T cells drives graft-versus-host disease lethality.
Saha A; O'Connor RS; Thangavelu G; Lovitch SB; Dandamudi DB; Wilson CB; Vincent BG; Tkachev V; Pawlicki JM; Furlan SN; Kean LS; Aoyama K; Taylor PA; Panoskaltsis-Mortari A; Foncea R; Ranganathan P; Devine SM; Burrill JS; Guo L; Sacristan C; Snyder NW; Blair IA; Milone MC; Dustin ML; Riley JL; Bernlohr DA; Murphy WJ; Fife BT; Munn DH; Miller JS; Serody JS; Freeman GJ; Sharpe AH; Turka LA; Blazar BR
J Clin Invest; 2016 Jul; 126(7):2642-60. PubMed ID: 27294527
[TBL] [Abstract][Full Text] [Related]
18. Intermittent hypoxia inhibits anti-tumor immune response via regulating PD-L1 expression in lung cancer cells and tumor-associated macrophages.
Cui Z; Ruan Z; Li M; Ren R; Ma Y; Zeng J; Sun J; Ye W; Xu W; Guo X; Xu D; Zhang L
Int Immunopharmacol; 2023 Sep; 122():110652. PubMed ID: 37478668
[TBL] [Abstract][Full Text] [Related]
19. Programmed Death-Ligand 1 on Antigen-presenting Cells Facilitates the Induction of Antigen-specific Cytotoxic T Lymphocytes: Application to Adoptive T-Cell Immunotherapy.
Goto T; Nishida T; Takagi E; Miyao K; Koyama D; Sakemura R; Hanajiri R; Watanabe K; Imahashi N; Terakura S; Murata M; Kiyoi H
J Immunother; 2016 Oct; 39(8):306-15. PubMed ID: 27548033
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of programmed death-1 on T cells and programmed death ligand-1 on monocytes in septic shock patients.
Zhang Y; Li J; Lou J; Zhou Y; Bo L; Zhu J; Zhu K; Wan X; Cai Z; Deng X
Crit Care; 2011; 15(1):R70. PubMed ID: 21349174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
